关注
John Lee
John Lee
Janssen Pharmaceuticals
在 its.jnj.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
J Tsai, JT Lee, W Wang, J Zhang, H Cho, S Mamo, R Bremer, S Gillette, ...
Proceedings of the National Academy of Sciences 105 (8), 3041-3046, 2008
15272008
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy
F Chang, JT Lee, PM Navolanic, LS Steelman, JG Shelton, WL Blalock, ...
Leukemia 17 (3), 590, 2003
14762003
Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K
J Villanueva, A Vultur, JT Lee, R Somasundaram, M Fukunaga-Kalabis, ...
Cancer cell 18 (6), 683-695, 2010
14312010
Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention
F Chang, LS Steelman, JT Lee, JG Shelton, PM Navolanic, WL Blalock, ...
Leukemia 17 (7), 1263, 2003
9972003
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance
JA McCubrey, LS Steelman, SL Abrams, JT Lee, F Chang, FE Bertrand, ...
Advances in enzyme regulation 46 (1), 249-279, 2006
8272006
Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway
F Chang, LS Steelman, JG Shelton, JT Lee, PM Navolanic, WL Blalock, ...
International journal of oncology 22 (3), 469-480, 2003
5562003
The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia
JT Lee Jr, JA McCubrey
Leukemia 16 (4), 486, 2002
3582002
Phosphatidylinositol 3′-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells
JT Lee, LS Steelman, JA McCubrey
Cancer Research 64 (22), 8397-8404, 2004
2232004
Human dermal stem cells differentiate into functional epidermal melanocytes
L Li, M Fukunaga-Kalabis, H Yu, X Xu, J Kong, JT Lee, M Herlyn
J Cell Sci 123 (6), 853-860, 2010
2002010
PLX4032, a potent inhibitor of the B‐Raf V600E oncogene, selectively inhibits V600E‐positive melanomas
JT Lee, L Li, PA Brafford, M Van Den Eijnden, MB Halloran, K Sproesser, ...
Pigment cell & melanoma research 23 (6), 820-827, 2010
1922010
Targeting prostate cancer based on signal transduction and cell cycle pathways
JT Lee, BD Lehmann, DM Terrian, WH Chappell, F Stivala, M Libra, ...
Cell cycle 7 (12), 1745-1762, 2008
1322008
Active Notch1 confers a transformed phenotype to primary human melanocytes
CC Pinnix, JT Lee, ZJ Liu, R McDaid, K Balint, LJ Beverly, PA Brafford, ...
Cancer research 69 (13), 5312-5320, 2009
1302009
Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells
JG Shelton, LS Steelman, JT Lee, SL Knapp, WL Blalock, PW Moye, ...
Oncogene 22 (16), 2478, 2003
1222003
Targeting the Raf/MEK/ERK pathway with small-molecule inhibitors.
JA McCubrey, M Milella, A Tafuri, AM Martelli, P Lunghi, A Bonati, ...
Current opinion in investigational drugs (London, England: 2000) 9 (6), 614-630, 2008
1172008
Microenvironmental influences in melanoma progression
JT Lee, M Herlyn
Journal of cellular biochemistry 101 (4), 862-872, 2007
1022007
Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels
KSM Smalley, R Contractor, NK Haass, JT Lee, KL Nathanson, ...
British journal of cancer 96 (3), 445, 2007
1012007
Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cells.
JA McCubrey, JT Lee, LS Steelman, WL Blalock, PW Moye, F Chang, ...
Cancer detection and prevention 25 (4), 375-393, 2001
892001
The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes
H Yu, R McDaid, J Lee, P Possik, L Li, SM Kumar, DE Elder, P Van Belle, ...
The American journal of pathology 174 (6), 2367-2377, 2009
832009
Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia
WL Blalock, PM Navolanic, LS Steelman, JG Shelton, PW Moye, JT Lee, ...
Leukemia 17 (6), 1058, 2003
832003
Participation of the calcium/calmodulin-dependent kinases in hydrogen peroxide-induced IκB phosphorylation in human T lymphocytes
CJ Howe, MM LaHair, JA Maxwell, JT Lee, PJ Robinson, ...
Journal of Biological Chemistry 277 (34), 30469-30476, 2002
722002
系统目前无法执行此操作,请稍后再试。
文章 1–20